Download PDF
Semin Reprod Med 2023; 41(06): 258-266
DOI: 10.1055/s-0043-1777837
Review Article

Gonadotropins in the Management of Couple Infertility: Toward the Rational Use of an Empirical Therapy

Marilina Romeo
1   Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
2   Department of Medical Specialties, Unit of Endocrinology, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy
,
Valeria Donno
3   Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy
,
Giorgia Spaggiari
2   Department of Medical Specialties, Unit of Endocrinology, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy
4   Department of Medical Specialties, Unit of Andrology and Sexual Medicine, Unit of Endocrinology, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy
,
Antonio R.M. Granata
2   Department of Medical Specialties, Unit of Endocrinology, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy
4   Department of Medical Specialties, Unit of Andrology and Sexual Medicine, Unit of Endocrinology, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy
,
Manuela Simoni
1   Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
2   Department of Medical Specialties, Unit of Endocrinology, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy
,
Antonio La Marca
3   Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy
,
Daniele Santi 
1   Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
2   Department of Medical Specialties, Unit of Endocrinology, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy
4   Department of Medical Specialties, Unit of Andrology and Sexual Medicine, Unit of Endocrinology, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Although epidemiology shows that both men and woman can experience infertility, the female partner usually experiences most of the diagnostic and therapeutic burden. Thus, management of couple infertility is a unique example of gender inequality. The use of exogenous gonadotropins in assisted reproductive technology (ART) to induce multifollicular growth is well consolidated in women, but the same is not done with the same level of confidence and purpose in infertile men. Indeed, the treatment of idiopathic male infertility is based on an empirical approach that involves administration of the follicle-stimulating hormone (FSH) in dosages within the replacement therapy range. This treatment has so far been attempted when the endogenous FSH serum levels are within the reference ranges. According to the most recent evidence, a “substitutive” FSH administration may not be effective enough, while a stimulatory approach could boost spermatogenesis over its basal levels without adverse extragonadal effects. This article aims to describe the rationale behind the empirical application of gonadotropins in couple infertility, highlighting the need for a change in the therapeutic approach, especially for the male partner.

Keywords

couple infertility - female infertility - gonadotropins - male infertility - stimulatory approach

Authors' Contribution

M.R., G.S., and D.S. conceived and designed the review; M.R. and V.D. drafted the manuscript; G.S., A.R.M.G., A.L.M., M.S., and D.S. revised the article critically for important intellectual content. All authors read and approved the final manuscript.




Publication History

Article published online:
29 December 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 World Health Organization. WHO fact sheet on infertility. Glob Reprod Health 2021; 6 (01) e52
    CrossrefPubMedGoogle Scholar
  • 2 Björndahl L, Kirkman Brown J. other Editorial Board Members of the WHO Laboratory Manual for the Examination and Processing of Human Semen. The sixth edition of the WHO Laboratory Manual for the Examination and Processing of Human Semen: ensuring quality and standardization in basic examination of human ejaculates. Fertil Steril 2022; 117 (02) 246-251
    CrossrefPubMedGoogle Scholar
  • 3 UCLA Health. Infertility. 2020 Accessed December 7, 2023 at: http://obgyn.ucla.edu/infertility
    PubMed
  • 4 Anawalt BD. Approach to male infertility and induction of spermatogenesis. J Clin Endocrinol Metab 2013; 98 (09) 3532-3542
    CrossrefPubMedGoogle Scholar
  • 5 Turner KA, Rambhatla A, Schon S. et al. Male infertility is a women's health issue - research and clinical evaluation of male infertility is needed. Cells 2020; 9 (04) 990
    CrossrefPubMedGoogle Scholar
  • 6 Patel VN, Ginsburg KB, Etnyre E. et al. Practice patterns for the treatment of idiopathic infertility: is there a role for advanced semen testing?. AME Med J 2019; 4 DOI: 10.21037/amj.2019.01.01.
    CrossrefPubMedGoogle Scholar
  • 7 Simoni M, Santi D. FSH treatment of male idiopathic infertility: time for a paradigm change. Andrology 2020; 8 (03) 535-544
    CrossrefPubMedGoogle Scholar
  • 8 Isidori AM, Pozza C, Gianfrilli D, Isidori A. Medical treatment to improve sperm quality. Reprod Biomed Online 2006; 12 (06) 704-714
    CrossrefPubMedGoogle Scholar
  • 9 Villani MT, Morini D, Spaggiari G. et al. Are sperm parameters able to predict the success of assisted reproductive technology? A retrospective analysis of over 22,000 assisted reproductive technology cycles. Andrology 2022; 10 (02) 310-321
    CrossrefPubMedGoogle Scholar
  • 10 Santi D, Spaggiari G, Granata ARM, Simoni M. Real-world evidence analysis of the follicle-stimulating hormone use in male idiopathic infertility. Best Pract Res Clin Obstet Gynaecol 2022; 85 (Pt B): 121-133
    CrossrefPubMedGoogle Scholar
  • 11 Esteves SC, Achermann APP, Simoni M, Santi D, Casarini L. Male infertility and gonadotropin treatment: What can we learn from real-world data?. Best Pract Res Clin Obstet Gynaecol 2023; 86: 102310
    CrossrefPubMedGoogle Scholar
  • 12 Fleseriu M, Hashim IA, Karavitaki N. et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101 (11) 3888-3921
    CrossrefPubMedGoogle Scholar
  • 13 Rastrelli G, Corona G, Mannucci E, Maggi M. Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology 2014; 2 (06) 794-808
    CrossrefPubMedGoogle Scholar
  • 14 Pallotti F, Barbonetti A, Rastrelli G, Santi D, Corona G, Lombardo F. The impact of male factors and their correct and early diagnosis in the infertile couple's pathway: 2021 perspectives. J Endocrinol Invest 2022; 45 (10) 1807-1822
    CrossrefPubMedGoogle Scholar
  • 15 Alviggi C, Humaidan P, Ezcurra D. Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. Reprod Biol Endocrinol 2012; 10: 9
    CrossrefPubMedGoogle Scholar
  • 16 Foran D, Chen R, Jayasena CN, Minhas S, Tharakan T. The use of hormone stimulation in male infertility. Curr Opin Pharmacol 2023; 68: 102333
    CrossrefPubMedGoogle Scholar
  • 17 de Kretser DM. Male infertility. Lancet 1997; 349 (9054): 787-790
    CrossrefPubMedGoogle Scholar
  • 18 Romeo M, Spaggiari G, Nuzzo F, Granata ARM, Simoni M, Santi D. Follicle-stimulating hormone effectiveness in male idiopathic infertility: What happens in daily practice?. Andrology 2023; 11 (03) 478-488
    CrossrefPubMedGoogle Scholar
  • 19 Oduwole OO, Peltoketo H, Huhtaniemi IT. Role of follicle-stimulating hormone in spermatogenesis. Front Endocrinol (Lausanne) 2018; 9: 763
    CrossrefPubMedGoogle Scholar
  • 20 Oduwole OO, Peltoketo H, Poliandri A. et al. Constitutively active follicle-stimulating hormone receptor enables androgen-independent spermatogenesis. J Clin Invest 2018; 128 (05) 1787-1792
    CrossrefPubMedGoogle Scholar
  • 21 Wang JM, Li ZF, Yang WX, Tan FQ. Follicle-stimulating hormone signaling in Sertoli cells: a licence to the early stages of spermatogenesis. Reprod Biol Endocrinol 2022; 20 (01) 97
    CrossrefPubMedGoogle Scholar
  • 22 Oduwole OO, Huhtaniemi IT, Misrahi M. The roles of luteinizing hormone, follicle-stimulating hormone and testosterone in spermatogenesis and folliculogenesis revisited. Int J Mol Sci 2021; 22 (23) 12735
    CrossrefPubMedGoogle Scholar
  • 23 Casarini L, Santi D, Marshall GR, Simoni M. Luteinizing hormone (LH). In: Huhtaniemi I, Martini L. eds. Encyclopedia of Endocrine Diseases. 2nd ed.. Oxford: Academic Press; 2018: 142-148
    Google Scholar
  • 24 Santi D, Crépieux P, Reiter E. et al. Follicle-stimulating hormone (FSH) action on spermatogenesis: a focus on physiological and therapeutic roles. J Clin Med 2020; 9 (04) 1014
    CrossrefPubMedGoogle Scholar
  • 25 Siegel ET, Kim HG, Nishimoto HK, Layman LC. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models. Reprod Sci 2013; 20 (03) 211-233
    CrossrefPubMedGoogle Scholar
  • 26 Tapanainen JS, Aittomäki K, Min J, Vaskivuo T, Huhtaniemi IT. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 1997; 15 (02) 205-206
    CrossrefPubMedGoogle Scholar
  • 27 Huhtaniemi I. Mechanisms in endocrinology: hormonal regulation of spermatogenesis: mutant mice challenging old paradigms. Eur J Endocrinol 2018; 179 (03) R143-R150
    CrossrefPubMedGoogle Scholar
  • 28 Simoni M, Huhtaniemi I, Casarini L, Santi D. Editorial: follicle-stimulating hormone: fertility and beyond-volume II. Front Endocrinol (Lausanne) 2022; 13: 991106
    CrossrefPubMedGoogle Scholar
  • 29 Ma X, Dong Y, Matzuk MM, Kumar TR. Targeted disruption of luteinizing hormone beta-subunit leads to hypogonadism, defects in gonadal steroidogenesis, and infertility. Proc Natl Acad Sci U S A 2004; 101 (49) 17294-17299
    CrossrefPubMedGoogle Scholar
  • 30 El-Gehani F, Zhang FP, Pakarinen P, Rannikko A, Huhtaniemi I. Gonadotropin-independent regulation of steroidogenesis in the fetal rat testis. Biol Reprod 1998; 58 (01) 116-123
    CrossrefPubMedGoogle Scholar
  • 31 Lei ZM, Mishra S, Zou W. et al. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol Endocrinol 2001; 15 (01) 184-200
    CrossrefPubMedGoogle Scholar
  • 32 Santi D, De Vincentis S, Alfano P. et al. Use of follicle-stimulating hormone for the male partner of idiopathic infertile couples in Italy: results from a multicentre, observational, clinical practice survey. Andrology 2020; 8 (03) 637-644
    CrossrefPubMedGoogle Scholar
  • 33 Foresta C, Bettella A, Merico M, Garolla A, Ferlin A, Rossato M. Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertil Steril 2002; 77 (02) 238-244
    CrossrefPubMedGoogle Scholar
  • 34 Ding YM, Zhang XJ, Li JP. et al. Treatment of idiopathic oligozoospermia with recombinant human follicle-stimulating hormone: a prospective, randomized, double-blind, placebo-controlled clinical study in Chinese population. Clin Endocrinol (Oxf) 2015; 83 (06) 866-871
    CrossrefPubMedGoogle Scholar
  • 35 Paradisi R, Busacchi P, Seracchioli R, Porcu E, Venturoli S. Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study. Fertil Steril 2006; 86 (03) 728-731
    CrossrefPubMedGoogle Scholar
  • 36 Ferlin A, Calogero AE, Krausz C. et al. Management of male factor infertility: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) : Endorsing Organization: Italian Society of Embryology, Reproduction, and Research (SIERR). J Endocrinol Invest 2022; 45 (05) 1085-1113
    CrossrefPubMedGoogle Scholar
  • 37 Colpi GM, Francavilla S, Haidl G. et al. European Academy of Andrology guideline management of oligo-astheno-teratozoospermia. Andrology 2018; 6 (04) 513-524
    CrossrefPubMedGoogle Scholar
  • 38 Foresta C, Bettella A, Ferlin A, Garolla A, Rossato M. Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males. Fertil Steril 1998; 69 (04) 636-642
    CrossrefPubMedGoogle Scholar
  • 39 AIFA. Note 74: Italian Medicines Agency; 2010. Accessed December 7, 2023 at: http://www.agenziafarmaco.gov.it/it/content/nota-74
    PubMed
  • 40 Attia AM, Abou-Setta AM, Al-Inany HG. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database Syst Rev 2013; (08) CD005071
    PubMedGoogle Scholar
  • 41 Santi D, Granata AR, Simoni M. Follicle-stimulating hormone treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis. Endocr Connect 2015; 4 (03) R46-R58
    CrossrefPubMedGoogle Scholar
  • 42 Cannarella R, La Vignera S, Condorelli RA, Mongioi LM, Calogero AE. FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies. Asian J Androl 2020; 22 (03) 309-316
    CrossrefPubMedGoogle Scholar
  • 43 Santi D, Granata AR, Simoni M. FSH treatment of male idiopathic infertility improves pregnancy rate: a meta-analysis. Endocr Connect 2015; 4 (03) R46-R58
    CrossrefPubMedGoogle Scholar
  • 44 Berger ML, Sox H, Willke RJ. et al. Good practices for real-world data studies of treatment and/or comparative effectiveness: recommendations from the Joint ISPOR-ISPE Special Task Force on Real-World Evidence in Health Care Decision Making. Value Health 2017; 20 (08) 1003-1008
    CrossrefPubMedGoogle Scholar
  • 45 Usadi RS, Merriam KS. On-label and off-label drug use in the treatment of female infertility. Fertil Steril 2015; 103 (03) 583-594
    CrossrefPubMedGoogle Scholar
  • 46 Casarini L, Brigante G, Simoni M, Santi D. Clinical applications of gonadotropins in the female: assisted reproduction and beyond. Prog Mol Biol Transl Sci 2016; 143: 85-119
    CrossrefPubMedGoogle Scholar
  • 47 Gallos ID, Eapen A, Price MJ. et al. Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis. Cochrane Database Syst Rev 2017
    PubMedGoogle Scholar
  • 48 Scarselli G, Comparetto C, Coccia ME. Analoghi del GnRH: agonisti e antagonisti. In: Verducci, editor. Ginecologia e Ostetricia. Roma: 2006: 1729-1744
    Google Scholar
  • 49 Kuang Y, Chen Q, Fu Y. et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 2015; 104 (01) 62-70.e3
    CrossrefPubMedGoogle Scholar
  • 50 Imani B, Eijkemans MJ, Faessen GH, Bouchard P, Giudice LC, Fauser BC. Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertil Steril 2002; 77 (01) 83-90
    CrossrefPubMedGoogle Scholar
  • 51 Tay LK, Russo J. Effect of human chorionic gonadotrophin on 7,12-dimethylbenz[a]anthracene-induced DNA binding and repair synthesis by rat mammary epithelial cells. Chem Biol Interact 1985; 55 (1-2): 13-21
    CrossrefPubMedGoogle Scholar
  • 52 Prodromidou A, Anagnostou E, Mavrogianni D. et al. Past, present, and future of gonadotropin use in controlled ovarian stimulation during assisted reproductive techniques. Cureus 2021; 13 (06) e15663
    PubMedGoogle Scholar
  • 53 The Eshre Guideline Group on Ovarian Stimulation. Bosch E, Broer S, Griesinger G. et al. ESHRE guideline: ovarian stimulation for IVF/ICSI. Hum Reprod Open 2020; 2020 (02) hoaa009
    CrossrefPubMedGoogle Scholar
  • 54 Kligman I, Rosenwaks Z. Differentiating clinical profiles: predicting good responders, poor responders, and hyperresponders. Fertil Steril 2001; 76 (06) 1185-1190
    CrossrefPubMedGoogle Scholar
  • 55 Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of ‘low prognosis patients in assisted reproductive technology’ and its proposed marker of successful outcome. F1000 Res 2016; 5: 2911
    CrossrefPubMedGoogle Scholar
  • 56 Esteves SC, Roque M, Bedoschi GM, Conforti A, Humaidan P, Alviggi C. Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON Criteria - The Why. Front Endocrinol (Lausanne) 2018; 9: 461
    CrossrefPubMedGoogle Scholar
  • 57 Haahr T, Esteves SC, Humaidan P. Poor definition of poor-ovarian response results in misleading clinical recommendations. Hum Reprod 2018; 33 (05) 979-980
    CrossrefPubMedGoogle Scholar
  • 58 Griesinger G, Verweij PJ, Gates D. et al. Prediction of ovarian hyperstimulation syndrome in patients treated with corifollitropin alfa or rFSH in a GnRH antagonist protocol. PLoS One 2016; 11 (03) e0149615
    CrossrefPubMedGoogle Scholar
  • 59 Medwin C, Rozen G, Agresta F, Nassar N, Polyakov A. The ovarian hyperstimulation that truly matters: admissions, severity and prevention strategies. Aust N Z J Obstet Gynaecol 2023; 63 (04) 583-587
    CrossrefPubMedGoogle Scholar
  • 60 Drakopoulos P, Bardhi E, Boudry L. et al. Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept. Ther Adv Reprod Health 2020; 14: 2633494120941480
    CrossrefPubMedGoogle Scholar
  • 61 Devroey P, Polyzos NP, Blockeel C. An OHSS-free clinic by segmentation of IVF treatment. Hum Reprod 2011; 26 (10) 2593-2597
    CrossrefPubMedGoogle Scholar
  • 62 Chrusciel M, Ponikwicka-Tyszko D, Wolczynski S, Huhtaniemi I, Rahman NA. Extragonadal FSHR expression and function - Is it real?. Front Endocrinol (Lausanne) 2019; 10: 32
    CrossrefPubMedGoogle Scholar
  • 63 Udell JA, Lu H, Redelmeier DA. Failure of fertility therapy and subsequent adverse cardiovascular events. CMAJ 2017; 189 (10) E391-E397
    CrossrefPubMedGoogle Scholar
  • 64 Dayan N, Filion KB, Okano M. et al. Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol 2017; 70 (10) 1203-1213
    CrossrefPubMedGoogle Scholar
  • 65 Radu A, Pichon C, Camparo P. et al. Expression of follicle-stimulating hormone receptor in tumor blood vessels. N Engl J Med 2010; 363 (17) 1621-1630
    CrossrefPubMedGoogle Scholar
  • 66 Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet 2011; 377 (9773): 1276-1287
    CrossrefPubMedGoogle Scholar
  • 67 Randolph Jr JF, Zheng H, Sowers MR. et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 2011; 96 (03) 746-754
    CrossrefPubMedGoogle Scholar
  • 68 Devleta B, Adem B, Senada S. Hypergonadotropic amenorrhea and bone density: new approach to an old problem. J Bone Miner Metab 2004; 22 (04) 360-364
    CrossrefPubMedGoogle Scholar
  • 69 Sun L, Zhang Z, Zhu LL. et al. Further evidence for direct pro-resorptive actions of FSH. Biochem Biophys Res Commun 2010; 394 (01) 6-11
    CrossrefPubMedGoogle Scholar
  • 70 Drake MT, McCready LK, Hoey KA, Atkinson EJ, Khosla S. Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women. J Clin Endocrinol Metab 2010; 95 (11) 5063-5068
    CrossrefPubMedGoogle Scholar
  • 71 Munir JA, Wu H, Bauer K. et al. The perimenopausal atherosclerosis transition: relationships between calcified and noncalcified coronary, aortic, and carotid atherosclerosis and risk factors and hormone levels. Menopause 2012; 19 (01) 10-15
    CrossrefPubMedGoogle Scholar
  • 72 Wildman RP, Colvin AB, Powell LH. et al. Associations of endogenous sex hormones with the vasculature in menopausal women: the Study of Women's Health Across the Nation (SWAN). Menopause 2008; 15 (03) 414-421
    CrossrefPubMedGoogle Scholar
  • 73 Wang N, Shao H, Chen Y. et al. Follicle-stimulating hormone, its association with cardiometabolic risk factors, and 10-year risk of cardiovascular disease in postmenopausal women. J Am Heart Assoc 2017; 6 (09) e005918
    CrossrefPubMedGoogle Scholar
  • 74 Sciurano RB, Luna Hisano CV, Rahn MI. et al. Focal spermatogenesis originates in euploid germ cells in classical Klinefelter patients. Hum Reprod 2009; 24 (09) 2353-2360
    CrossrefPubMedGoogle Scholar
  • 75 Grinspon RP, Habib C, Bedecarrás P, Gottlieb S, Rey RA. Compensatory function of the remaining testis is dissociated in boys and adolescents with monorchidism. Eur J Endocrinol 2016; 174 (03) 399-407
    CrossrefPubMedGoogle Scholar
  • 76 Laron Z, Zilka E. Compensatory hypertrophy of testicle in unilateral cryptorchidism. J Clin Endocrinol Metab 1969; 29 (11) 1409-1413
    CrossrefPubMedGoogle Scholar
  • 77 Laron Z, Dickerman Z, Ritterman I, Kaufman H. Follow-up of boys with unilateral compensatory testicular hypertrophy. Fertil Steril 1980; 33 (03) 297-301
    CrossrefPubMedGoogle Scholar
  • 78 Brown JL, Schoenemann HM, Chakraborty PK, Stuart LD, Dahl KD. Increased bioactivity of serum follicle-stimulating hormone, but not luteinizing hormone, following hemicastration in ram lambs. Biol Reprod 1990; 43 (04) 548-553
    CrossrefPubMedGoogle Scholar
  • 79 Cunningham GR, Tindall DJ, Huckins C, Means AR. Mechanisms for the testicular hypertrophy which follows hemicastration. Endocrinology 1978; 102 (01) 16-23
    CrossrefPubMedGoogle Scholar
  • 80 Mana DL, Belingeri MS, Manavela M. et al. FSH-producing pituitary macroadenoma: report of 2 cases with clinical manifestations of hormone excess. AACE Clin Case Rep 2016; 2 (01) e7-e11
    CrossrefPubMedGoogle Scholar
  • 81 Dahlqvist P, Koskinen LO, Brännström T, Hägg E. Testicular enlargement in a patient with a FSH-secreting pituitary adenoma. Endocrine 2010; 37 (02) 289-293
    CrossrefPubMedGoogle Scholar
  • 82 Gromoll J, Pekel E, Nieschlag E. The structure and organization of the human follicle-stimulating hormone receptor (FSHR) gene. Genomics 1996; 35 (02) 308-311
    CrossrefPubMedGoogle Scholar
  • 83 Spaggiari G, Granata ARM, Santi D. Testicular ultrasound inhomogeneity is an informative parameter for fertility evaluation. Asian J Androl 2020; 22 (03) 302-308
    CrossrefPubMedGoogle Scholar
  • 84 Casarini L, Santi D, Marino M. Impact of gene polymorphisms of gonadotropins and their receptors on human reproductive success. Reproduction 2015; 150 (06) R175-R184
    CrossrefPubMedGoogle Scholar
  • 85 Alviggi C, Conforti A, Santi D. et al. Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis. Hum Reprod Update 2018; 24 (05) 599-614
    CrossrefPubMedGoogle Scholar
  • 86 Simoni M, Santi D, Negri L. et al. Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study. Hum Reprod 2016; 31 (09) 1960-1969
    CrossrefPubMedGoogle Scholar
  • 87 Ferlin A, Vinanzi C, Selice R, Garolla A, Frigo AC, Foresta C. Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter. Fertil Steril 2011; 96 (06) 1344-1349.e2
    CrossrefPubMedGoogle Scholar
  • 88 Esteves SC, Humaidan P, Ubaldi FM. et al. APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function. Reprod Biomed Online 2023
    PubMedGoogle Scholar
  • 89 Caretto A, Lanzi R, Piani C, Molgora M, Mortini P, Losa M. Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas. Pituitary 2017; 20 (05) 553-560
    CrossrefPubMedGoogle Scholar
  • 90 Lussiana C, Guani B, Mari C, Restagno G, Massobrio M, Revelli A. Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene. Obstet Gynecol Surv 2008; 63 (12) 785-795
    CrossrefPubMedGoogle Scholar
  • 91 Hiller-Sturmhöfel S, Bartke A. The endocrine system: an overview. Alcohol Health Res World 1998; 22 (03) 153-164
    PubMedGoogle Scholar
  • 92 Fleseriu M, Auchus R, Bancos I. et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol 2021; 9 (12) 847-875
    CrossrefPubMedGoogle Scholar
  • 93 Giustina A, Barkan A, Beckers A. et al. A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab 2020; 105 (04) dgz096
    CrossrefPubMedGoogle Scholar